High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosingRobert N. Plasschaert, Chris Mason, Luigi Barbarossa et al.|Molecular Therapy|2022Cited by 13
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K. Yoon, Niek P. van Til, Jeffrey W. Schindler et al.|Molecular Therapy|2024Cited by 5
Genetically engineered microglia-like cells have therapeutic potential for neurodegenerative diseaseRobert N. Plasschaert, Chris Mason, Mark P. DeAndrade et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2
Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K. Yoon, Niek P. van Til, Jeffrey W. Schindler et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0